Vimarsana
Biggest News Aggregation in the World

Achieve Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Achieve Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Achieve Life Sciences Today - Breaking & Trending Today

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors - Vimarsana News

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors

Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to...

New Treatment Could Help Millions of Vape Users Quit - Vimarsana News

New Treatment Could Help Millions of Vape Users Quit

A new nicotine cessation approach could help the 11 million U.S. adults quit vaping. Here's what to know about the first possible FDA-authorized treatment for vaping.

Source: webmd.com
Achieve Life Sciences, Inc. Expected to Earn Q2 2024 Earnings of ($0.21) Per Share (NASDAQ:ACHV) - Vimarsana News

Achieve Life Sciences, Inc. Expected to Earn Q2 2024 Earnings of ($0.21) Per Share (NASDAQ:ACHV)

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) – Equities researchers at Zacks Small Cap issued their Q2 2024 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten anticipates that the biopharmaceutical company will earn ($0.21) per share […]

A Plant-Based Medication Helps People Quit Vaping - Vimarsana News

A Plant-Based Medication Helps People Quit Vaping

Today Headline Breaking News

Cytisinicline, a Plant-Based Medication, Could Help Curb E-Cigarette Use Among Adults Patients - Vimarsana News

Cytisinicline, a Plant-Based Medication, Could Help Curb E-Cigarette Use Among Adults Patients

Data from the ORCA-V trial suggests cytisinicline, a plant-based medication, aids adults in quitting e-cigarettes.